India, March 26 -- Sanofi India and SanofiHealthcare India, and Cipla have announced an exclusive partnership for distribution andpromotion of Sanofi India's Central Nervous System(CNS) product range in India.

As a part of this partnership, Cipla will be responsible for thedistribution of Sanofi India's six CNS brands including Frisium, a leading brandin the anti-epileptic medication category.

WhileSanofi India will continue to own, import, and manufacture its complete range of CNS productsacross plants in India and internationally, Mumbai-based pharmaceutical company Cipla will leverage its capabilities androbust India-wide network of strong marketing and sales professionals, distributors, institutions, and market outreach programmesto...